Table 1 Baseline characteristics of males subjects
From: The association between liver enzymes and risk of type 2 diabetes: the Namwon study
Variables | Males (n = 2,603) | ||
|---|---|---|---|
Diabetes ‡ | Non-diabetes | p-value* | |
Age (years) | 62.4 (7.8) | 62.4 (7.5) | 0.848 |
Body mass index (kg/m2) | 24.6 (2.9) | 23.7 (2.7) | <0.001 |
Waist circumference (cm) | 87.1 (7.6) | 84.7 (7.6) | <0.001 |
AST (units/l) | 26 (21–32) | 25 (21–30) | 0.089 |
ALT (units/l) | 24 (18–34) | 21 (16–29) | <0.001 |
GGT (units/l) | 39 (24–74) | 30 (19–53) | 0.006 |
Fasting glucose (mg/dl) | 108.3 (13.8) | 100.1 (9.7) | <0.001 |
HOMA (%) | 1.54 (1.10) | 1.14 (1.13) | <0.001 |
Total cholesterol (mg/dl) | 183.6 (35.9) | 182.8 (34.1) | 0.658 |
HDL cholesterol (mg/dl) | 45.5 (11.7) | 47.2 (12.3) | 0.045 |
Triglycerides (mg/dl) | 152 (107–231) | 128 (88–194) | 0.002 |
C-reactive protein (mg/dl) | 0.08 (0.04-0.17) | 0.07 (0.03-0.16) | 0.757 |
Current drinker (%) | 151 (64.3) | 1,577 (66.7) | 0.490 |
Current smoker (%) | 81 (34.5) | 748 (31.6) | 0.548 |
Physical exercise (%) | 87 (37.0) | 819 (34.7) | 0.474 |